EX-99.1 2 brc-2013131xex991.htm SECOND QUARTER FISCAL 2013 PRESS RELEASE BRC-2013.1.31-EX 99.1


EXHIBIT 99.1
For More Information:
Investor contact: Aaron Pearce 414-438-6895
Media contact: Carole Herbstreit 414-438-6882


For Immediate Release


Brady Corporation Reports Fiscal 2013 Second Quarter Results and Announces Reorganization

MILWAUKEE (February 21, 2013)--Brady Corporation (NYSE: BRC) (“Brady” or “Company”), a world leader in identification solutions, today reported its financial results for the fiscal 2013 second quarter ended January 31, 2013 and also announced a reorganization of its business.

Quarter Ended January 31, 2013 Financial Results:
Sales for the fiscal 2013 second quarter ended January 31, 2013, were up 1.1 percent to $324.2 million compared to $320.6 million in the second quarter of fiscal 2012. Organic sales declined 3.1 percent, the impact of foreign currency translation increased sales by 0.2 percent, and acquisitions, net of divestitures added 4.0 percent. By segment, organic sales increased 0.6 percent in the Americas and decreased 5.0 percent in EMEA and 7.0 percent in the Asia-Pacific region.
During the second quarter of fiscal 2013, the Company acquired Precision Dynamics Corporation (“PDC”) for $301 million. PDC is a leader in identification products primarily for the healthcare sector with annual revenues of approximately $173 million. In connection with this acquisition, the Company incurred certain acquisition-related costs including a non-cash tax charge of $25.0 million related to the repatriation of cash to the U.S. and $5.1 million of other acquisition-related expenses. During the second quarter of fiscal 2013, the Company also realized a $5.2 million pre-tax gain on the settlement of an insurance claim related to the 2011 flood in Thailand. In the second quarter of last fiscal year, the Company recorded a non-cash impairment charge of $115.7 million for the write down of goodwill in the Asia-Pacific region. Non-routine and other items, along with restructuring charges are quantified on pages 11-12 of this news release for comparability purposes.
Net income (loss) in the fiscal 2013 second quarter was $(8.7) million compared to $(90.0) million in the same quarter last year. Non-GAAP net income* was $19.5 million in the second quarter of fiscal 2013, compared to $25.7 million in the second quarter of fiscal 2012.
Earnings (loss) per diluted Class A Common Share were $(0.17) in the second quarter of fiscal 2013 compared to $(1.72) in the same quarter last year. Non-GAAP Diluted Earnings per Class A Common Share* were $0.38 in the second quarter of fiscal 2013, compared to $0.49 in the second quarter of fiscal 2012.










Six Months Ended January 31, 2013 Financial Results:
Sales for the six-month period ended January 31, 2013, were down 1.3 percent to $661.8 million compared to $670.1 million in the same period last year. Organic sales were down 2.5 percent, the impact of foreign currency translation decreased sales by 1.0 percent, and acquisitions, net of divestitures added 2.2 percent.
Net income (loss) for the six months ended January 31, 2013 was $18.5 million compared to $(57.2) million in the same period of fiscal 2012. Non-GAAP net income* was $49.9 million for the six months ended January 31, 2013, compared to $58.5 million in the same period of fiscal 2012.
Earnings (loss) per diluted Class A Common Share were $0.36 for the six-month period ended January 31, 2013 compared to $(1.09) in the same period of fiscal 2012. Non-GAAP Diluted Earnings per Class A Common Share* were $0.97 for the six months ended January 31, 2013, compared to $1.12 in the same period in fiscal 2012.

Brady to Reorganize its Business:
Brady also reported that as part of its strategy to improve organic growth and profitability that it will be changing its organizational structure from geographically-based to an organization structured around three global business platforms: Identification Solutions, Workplace Safety and Die-Cut.
The Identification Solutions business will focus on innovative identification solutions for a broad range of applications including wire identification, product identification, safety and facility identification and healthcare identification. The Workplace Safety business will be expanding its multi-channel direct marketing model by providing a broader set of workplace safety products with an increased focus on e-business. The Die-Cut business will continue to provide precision solutions primarily to the global electronics industry. Mr. Matthew Williamson will lead the global Identification Solutions business. Mr. Williamson has been with Brady for 34 years and is currently serving as Vice President of the Company and President - Brady Americas. Mr. Scott Hoffman will lead the global Workplace Safety business. Mr. Hoffman has been with Brady for 27 years and is currently serving as Vice President - Corporate and Business Development of the Company. Mr. Stephen Millar will lead the Die-Cut business. Mr. Millar has been with Brady for 14 years and is currently serving as Vice President of the Company and President - Asia-Pacific. Peter Sephton, currently president of Brady's EMEA region, will be retiring from Brady effective July 31, 2013. Mr. Sephton will remain in his current role as Vice President of Brady and President - Brady EMEA through April 30, 2013 when he will resign these positions and will then assist with the transition to the new global business platforms through his retirement on July 31, 2013.

Commentary and Guidance:
“In the second quarter of fiscal 2013, we experienced slight organic sales growth in the Americas and we experienced a 5.0 percent organic sales decline in EMEA due to a challenging European economy. Our performance in Asia-Pacific was weaker than expected due to challenges in both our Australian business and our Thailand hard-disk drive business,” stated Brady's President and Chief Executive Officer, Frank M. Jaehnert. “The acquisition of PDC, a leader in the U.S. healthcare identification space, is a significant step forward in our move





into faster-growing end businesses with less cyclicality. PDC provides an important anchor position for Brady in the attractive healthcare sector, which is a sector in which we plan continued investment.”
Mr. Jaehnert continued, “We believe that our reorganization around global business platforms will create better alignment of resources required to deliver increasing levels of organic sales growth. We will also be able to create a leaner, flatter organization that is closer to the customer, allowing us to reduce costs by approximately $25 million to $30 million annually, some of which will be reinvested into growth initiatives. Costs to implement this reorganization are expected to range from $15 million to $18 million. The global business reorganization will be effective May 1, 2013 with most of the restructuring completed by the end of fiscal 2013. Looking forward, I am confident that the actions we are taking, including the acquisition of PDC and the reorganization around global businesses will accelerate future sales growth and increase future profitability.”
“We anticipate continuing pressure on organic sales for the remainder of fiscal 2013 as the global macro-economy remains sluggish,” said Brady's Chief Financial Officer, Thomas J. Felmer. “Based on what we see for the remainder of the year, and including $0.05 to $0.07 of anticipated earnings from PDC as well as some savings from restructuring activities in the fourth quarter, we expect earnings per diluted Class A Common Share to be towards the lower end of our prior guidance of between $2.20 and $2.40, exclusive of non-routine items, restructuring charges, and other items, for our full-year fiscal 2013, with the fourth quarter being stronger than the third quarter. This is based on exchange rates as of January 31, 2013 and a full-year income tax rate, excluding the impact of non-routine items, in the mid-to-upper 20 percent range.”

A webcast regarding Brady's fiscal 2013 second quarter financial results will be available at www.bradycorp.com beginning at 9:30 a.m. Central Time today.

Brady Corporation is an international manufacturer and marketer of complete solutions that identify and protect premises, products and people. Brady's products help customers increase safety, security, productivity and performance and include high-performance labels and signs, safety devices, printing systems and software, and precision die-cut materials. Founded in 1914, the company has millions of customers in electronics, telecommunications, manufacturing, electrical, construction, education, medical and a variety of other industries. Brady is headquartered in Milwaukee, Wisconsin and as of January 31, 2013 employed approximately 8,200 people at operations in the Americas, EMEA and Asia-Pacific. Brady's fiscal 2012 sales were approximately $1.32 billion. Brady stock trades on the New York Stock Exchange under the symbol BRC. More information is available on the Internet at www.bradycorp.com.

* See accompanying notes for Non-GAAP measures.











###
In this news release, statements that are not reported financial results or other historic information are “forward-looking statements.” These forward-looking statements relate to, among other things, the Company's future financial position, business strategy, targets, projected sales, costs, earnings, capital expenditures, debt levels and cash flows, and plans and objectives of management for future operations. The use of words such as “may,” “will,” “expect,” “intend,” “estimate,” “anticipate,” “believe,” “should,” “project” or “plan” or similar terminology are generally intended to identify forward-looking statements. These forward-looking statements by their nature address matters that are, to different degrees, uncertain and are subject to risks, assumptions, and other factors, some of which are beyond Brady's control, that could cause actual results to differ materially from those expressed or implied by such forward-looking statements. For Brady, uncertainties arise from: the length or severity of the current worldwide economic downturn or timing or strength of a subsequent recovery; increased usage of e-commerce allowing for ease of price transparency; future financial performance of major markets Brady serves, which include, without limitation, telecommunications, hard disk drive, manufacturing, electrical, construction, laboratory, education, governmental, public utility, computer, and transportation; future competition; changes in the supply of, or price for, parts and components; increased price pressure from suppliers and customers; Brady's ability to retain significant contracts and customers; fluctuations in currency rates versus the U.S. dollar; risks associated with international operations; difficulties associated with exports; risks associated with obtaining governmental approvals and maintaining regulatory compliance; Brady's ability to develop and successfully market new products; difficulties in making and integrating acquisitions; risks associated with newly acquired businesses; risks associated with restructuring plans; environmental, health and safety compliance costs and liabilities; technology changes and potential security violations to the Company's information technology systems; Brady's ability to maintain compliance with its debt covenants; increase in our level of debt; potential write-offs of Brady's substantial intangible assets; unforeseen tax consequences; and numerous other matters of national, regional and global scale, including those of a political, economic, business, competitive, and regulatory nature contained from time to time in Brady's U.S. Securities and Exchange Commission filings, including, but not limited to, those factors listed in the “Risk Factors” section within Item 1A of Part I of Brady's Form 10-K for the year ended July 31, 2012.

These uncertainties may cause Brady's actual future results to be materially different than those expressed in its forward-looking statements. Brady does not undertake to update its forward-looking statements except as required by law.








BRADY CORPORATION AND SUBSIDIARIES                                    
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(Dollars in Thousands, Except Per Share Amounts)
 
(Unaudited)
 
(Unaudited)
 
Three Months Ended January 31,
 
Six Months Ended January 31,
 
2013
 
2012
 
2013
 
2012
Net sales
$
324,182

 
$
320,584

 
$
661,828

 
$
670,092

Cost of products sold
174,130

 
167,279

 
347,156

 
348,956

Gross margin
150,052

 
153,305

 
314,672

 
321,136

Operating expenses:
 
 
 
 
 
 
 
Research and development
8,551

 
9,972

 
17,036

 
19,781

Selling, general and administrative
117,240

 
104,843

 
225,501

 
213,775

Restructuring charges
4,031

 

 
4,031

 

Impairment charge

 
115,688

 

 
115,688

Non-routine items
(5,220
)
 

 
(1,782
)
 

Total operating expenses
124,602

 
230,503

 
244,786

 
349,244

 
 
 
 
 
 
 
 
Operating income (loss)
25,450

 
(77,198
)
 
69,886

 
(28,108
)
 
 
 
 
 
 
 
 
Other income and (expense):
 
 
 
 
 
 
 
Investment and other income (expense)
897

 
812

 
1,294

 
610

Interest expense
(4,406
)
 
(4,933
)
 
(8,569
)
 
(9,980
)
 
 
 
 
 
 
 
 
Income before income taxes
21,941

 
(81,319
)
 
62,611

 
(37,478
)
 
 
 
 
 
 
 
 
Income taxes
30,625

 
8,635

 
44,107

 
19,744

 
 
 
 
 
 
 
 
Net (loss) income
$
(8,684
)
 
$
(89,954
)
 
$
18,504

 
$
(57,222
)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Per Class A Nonvoting Common Share:
 
 
 
 
 
 
 
Basic net income
$
(0.17
)
 
$
(1.72
)
 
$
0.36

 
$
(1.09
)
Diluted net income
$
(0.17
)
 
$
(1.72
)
 
$
0.36

 
$
(1.09
)
Dividends
$
0.19

 
$
0.185

 
$
0.38

 
$
0.37

 
 
 
 
 
 
 
 
Per Class B Voting Common Share:
 
 
 
 
 
 
 
Basic net income
$
(0.17
)
 
$
(1.72
)
 
$
0.34

 
$
(1.11
)
Diluted net income
$
(0.17
)
 
$
(1.72
)
 
$
0.34

 
$
(1.11
)
Dividends
$
0.19

 
$
0.185

 
$
0.36

 
$
0.35

 
 
 
 
 
 
 
 
Weighted average common shares outstanding (in thousands):
 
 
 
 
 
 
 
Basic
51,177

 
52,447

 
51,108

 
52,552

Diluted
51,177

 
52,447

 
51,507

 
52,552






BRADY CORPORATION AND SUBSIDIARIES                                
CONDENSED CONSOLIDATED BALANCE SHEETS
(Dollars in Thousands)
 
(Unaudited)
 
January 31, 2013
 
July 31, 2012
ASSETS
 
 
 
Current assets:
 
 
 
Cash and cash equivalents
$
141,311

 
$
305,900

Accounts receivable—net
229,219

 
199,006

Inventories:
 
 
 
Finished products
75,040

 
64,740

Work-in-process
17,549

 
15,377

Raw materials and supplies
32,242

 
25,407

Total inventories
124,831

 
105,524

Prepaid expenses and other current assets
47,656

 
40,424

Total current assets
543,017

 
650,854

Other assets:
 
 
 
Goodwill
877,972

 
676,791

Other intangible assets
185,495

 
84,119

Deferred income taxes
6,032

 
45,356

Other
22,711

 
20,584

Property, plant and equipment:
 
 
 
Cost:
 
 
 
Land
9,145

 
8,651

Buildings and improvements
105,501

 
101,962

Machinery and equipment
313,512

 
292,130

Construction in progress
12,444

 
10,417

 
440,602

 
413,160

Less accumulated depreciation
289,860

 
283,145

Property, plant and equipment—net
150,742

 
130,015

Total
$
1,785,969

 
$
1,607,719

LIABILITIES AND STOCKHOLDERS’ INVESTMENT
 
 
 
Current liabilities:
 
 
 
Notes payable
$
112,340

 
$

Accounts payable
103,197

 
86,646

Wages and amounts withheld from employees
40,564

 
54,629

Taxes, other than income taxes
8,313

 
9,307

Accrued income taxes
8,869

 
14,357

Other current liabilities
46,930

 
40,815

Current maturities on long-term debt
61,264

 
61,264

Total current liabilities
381,477

 
267,018

Long-term obligations, less current maturities
264,417

 
254,944

Other liabilities
102,225

 
76,404

Total liabilities
748,119

 
598,366

Stockholders’ investment:
 
 
 
Common stock:
 
 
 
Class A nonvoting common stock—Issued 51,261,487 and 51,261,487 shares, respectively and outstanding 47,711,496 and 47,630,926 shares, respectively
513

 
513

Class B voting common stock—Issued and outstanding, 3,538,628 shares
35

 
35

Additional paid-in capital
315,425

 
313,008

Earnings retained in the business
731,294

 
732,290

Treasury stock—3,234,991 and 3,245,561 shares, respectively of Class A nonvoting common stock, at cost
(88,354
)
 
(92,600
)
Accumulated other comprehensive income
81,475

 
59,411

Other
(2,538
)
 
(3,304
)
Total stockholders’ investment
1,037,850

 
1,009,353

Total
$
1,785,969

 
$
1,607,719







BRADY CORPORATION AND SUBSIDIARIES                                
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Dollars in Thousands)
 
(Unaudited)
Six Months Ended January 31,
 
2013
 
2012
Operating activities:
 
 
 
Net income (loss)
$
18,504

 
$
(57,222
)
Adjustments to reconcile net income to net cash provided by operating activities:
 
 
 
Depreciation and amortization
22,046

 
22,176

Non-cash portion of restructuring charges
200

 

Non-cash portion of stock-based compensation expense
6,868

 
5,506

Impairment charge

 
115,688

Loss (gain) on sales of businesses
3,138

 

Deferred income taxes
26,050

 
(4,831
)
Changes in operating assets and liabilities (net of effects of business acquisitions/divestitures):
 
 
 
Accounts receivable
(5,418
)
 
6,029

Inventories
(4,475
)
 
(11,814
)
Prepaid expenses and other assets
(2,772
)
 
(5,155
)
Accounts payable and accrued liabilities
(13,629
)
 
(36,297
)
Income taxes
(6,318
)
 
9,221

Net cash provided by operating activities
44,194

 
43,301

Investing activities:
 
 
 
Purchases of property, plant and equipment
(15,667
)
 
(11,100
)
Payments of contingent consideration

 
(2,580
)
Settlement of net investment hedges

 
(797
)
Acquisition of business, net of cash acquired
(300,757
)
 

Sales of businesses, net of cash retained
10,178

 

Other
(549
)
 
(128
)
Net cash used in investing activities
(306,795
)
 
(14,605
)
Financing activities:
 
 
 
Payment of dividends
(19,499
)
 
(19,452
)
Proceeds from issuance of common stock
4,409

 
2,301

Purchase of treasury stock
(5,121
)
 
(12,309
)
Proceeds from borrowings on credit revolver
220,000

 

Repayment of borrowings on credit revolver
(112,472
)
 

Income tax benefit from the exercise of stock options and deferred compensation distribution, and other
1,273

 
566

Net cash provided by (used in) financing activities
88,590

 
(28,894
)
Effect of exchange rate changes on cash
9,422

 
(9,442
)
Net decrease in cash and cash equivalents
(164,589
)
 
(9,640
)
Cash and cash equivalents, beginning of period
305,900

 
389,971

Cash and cash equivalents, end of period
$
141,311

 
$
380,331

Supplemental disclosures:
 
 
 
Cash paid during the period for:
 
 
 
Interest, net of capitalized interest
$
7,866

 
$
9,521

Income taxes, net of refunds
19,964

 
16,189

Acquisitions:
 
 
 
Fair value of assets acquired, net of cash
$
168,675

 
$

Liabilities assumed
(57,860
)
 

Goodwill
189,942

 

Net cash paid for acquisitions
$
300,757

 
$






 
 
 
 
 
 
 
Information by regional segment for the three and six months ended January 31, 2013 and 2012 is as follows:
 
 
 
 
 
 
 
(Dollars in Thousands)
Americas
EMEA
Asia-Pacific
Total Region
Corporate and Eliminations
Total
SALES TO EXTERNAL CUSTOMERS
Three months ended:
January 31, 2013
$
147,716

$
94,395

$
82,071

$
324,182


$
324,182

January 31, 2012
$
138,405

$
95,593

$
86,586

$
320,584


$
320,584

 
 
 
 
 
 
 
Six months ended:
January 31, 2013
$
296,408

$
187,628

$
177,792

$
661,828


$
661,828

January 31, 2012
$
292,267

$
192,949

$
184,876

$
670,092


$
670,092

 
 
 
 
 
 
 
SALES INFORMATION
Three months ended January 31, 2013:
    Organic
0.6
 %
(5.0
)%
(7.0
)%
(3.1
)%
%
(3.1
)%
    Currency
(0.4
)%
(0.3
)%
1.8
 %
0.2
 %
%
0.2
 %
    Acquisitions/Divestitures
6.5
 %
4.0
 %
0.0
 %
4.0
 %
%
4.0
 %
      Total
6.7
 %
(1.3
)%
(5.2
)%
1.1
 %
%
1.1
 %
 
 
 
 
 
 
 
Six months ended January 31, 2013:
    Organic
(0.1
)%
(4.1
)%
(4.6
)%
(2.5
)%
%
(2.5
)%
    Currency
(0.8
)%
(3.0
)%
0.8
 %
(1.0
)%
%
(1.0
)%
    Acquisitions/Divestitures
2.3
 %
4.3
 %
0.0
 %
2.2
 %
%
2.2
 %
      Total
1.4
 %
(2.8
)%
(3.8
)%
(1.3
)%
%
(1.3
)%
 
 
 
 
 
 
 
SEGMENT PROFIT
Three months ended:
January 31, 2013
$
32,336

$
23,723

$
5,514

$
61,573

$
(1,794
)
$
59,779

January 31, 2012
$
35,798

$
26,562

$
7,733

$
70,093

$
(2,359
)
$
67,734

      Percentage change
(9.7
)%
(10.7
)%
(28.7
)%
(12.2
)%
 
(11.7
)%
 
 
 
 
 
 
 
Six months ended:
January 31, 2013
$
76,969

$
47,290

$
17,569

$
141,828

$
(3,767
)
$
138,061

January 31, 2012
$
79,028

$
52,861

$
21,037

$
152,926

$
(5,622
)
$
147,304

      Percentage change
(2.6
)%
(10.5
)%
(16.5
)%
(7.3
)%
 
(6.3
)%







NET INCOME RECONCILIATION (dollars in thousands)
 
Three Months Ended January 31,
 
Six Months Ended January 31,
 
2013
 
2012
 
2013
 
2012
Total profit for reportable segments
$
61,573

 
$
70,093

 
$
141,828

 
$
152,926

Corporate and eliminations
(1,794
)
 
(2,359
)
 
(3,767
)
 
(5,622
)
Unallocated amounts:
 
 
 
 
 
 
 
    Administrative costs
(35,518
)
 
(29,244
)
 
(65,926
)
 
(59,724
)
    Restructuring charges
(4,031
)
 

 
(4,031
)
 

    Impairment charge

 
(115,688
)
 

 
(115,688
)
    Non-routine items
5,220

 

 
1,782

 

    Investment and other income
897

 
812

 
1,294

 
610

    Interest expense
(4,406
)
 
(4,933
)
 
(8,569
)
 
(9,980
)
Income (loss) before income taxes
21,941

 
(81,319
)
 
62,611

 
(37,478
)
Income taxes
30,625

 
8,635

 
44,107

 
19,744

       Net (loss) income
$
(8,684
)
 
$
(89,954
)
 
$
18,504

 
$
(57,222
)








GAAP TO NON-GAAP MEASURES
(Dollars in Thousands, Except Per Share Amounts)
In accordance with the U.S. Securities and Exchange Commission’s Regulation G, the following provides definitions of the non-GAAP measures used in the earnings release and the reconciliation to the most closely related GAAP measure.
EBITDA:
Brady is presenting EBITDA because it is used by many of our investors and lenders, and is presented as a convenience to them. EBITDA represents net income before interest expense, income taxes, depreciation and amortization. EBITDA is not a calculation based on generally accepted accounting principles ("GAAP"). The amounts included in the EBITDA calculation, however, are derived from amounts included in the Condensed Consolidated Statements of Income data. EBITDA should not be considered as an alternative to net income or operating income as an indicator of the Company's operating performance, or as an alternative to operating cash flows as a measure of liquidity. The EBITDA measure presented may not always be comparable to similarly titled measures reported by other companies due to differences in the components of the calculation.

 
 
 
Fiscal 2013
 
 
 
Q1
Q2
Q3
Q4
Total
EBITDA:
 
 
 
 
 
 
Net income (loss)
$
27,188

$
(8,684
)
 
 
$
18,504

 
 
Interest expense
4,163

4,406

 
 
8,569

 
 
Income taxes
13,482

30,625

 
 
44,107

 
 
Depreciation and amortization
10,675

11,371

 
 
22,046

 
 
 
 
 
 
 
 
 
EBITDA (non-GAAP measure)
$
55,508

$
37,718



$
93,226

 
 
 
 
 
 
 
 
 
 
 
Fiscal 2012
 
 
 
Q1
Q2
Q3
Q4
Total
EBITDA:
 
 
 
 
 
 
Net income (loss)
$
32,732

$
(89,954
)
$
27,652

$
11,659

$
(17,911
)
 
 
Interest expense
5,047

4,933

4,735

4,375

19,090

 
 
Income taxes
11,109

8,635

9,676

11,241

40,661

 
 
Depreciation and amortization
11,241

10,935

10,745

11,066

43,987

 
 
Impairment charge

115,688



115,688

 
 
 
 
 
 
 
 
 
EBITDA (non-GAAP measure)
$
60,129

$
50,237

$
52,808

$
38,341

$
201,515






GAAP TO NON-GAAP MEASURES
(Dollars in Thousands, Except Per Share Amounts)

Income Before Taxes Excluding Restructuring Charges, Non-Routine Items, and Other:
Brady is presenting the Non-GAAP measure "Income Before Taxes Excluding Restructuring Charges, Non-Routine Items, and Other." This is not a calculation based upon GAAP. The amounts included in this Non-GAAP measure are derived from amounts included in the Condensed Consolidated Statements of Income data. We do not view these items to be part of our sustainable results. We believe this profit measure provides an important perspective of underlying business trends and results and provides a more comparable measure from year to year. The table below provides a reconciliation of Income (Loss) Before Taxes to Income Before Taxes Excluding Restructuring Charges, Non-Routine Items, and Other:
 
 
 
 
Three Months Ended January 31,
 
Six Months Ended January 31,
 
 
 
 
2013
 
2012
 
2013
 
2012
Income (loss) before taxes (GAAP measure)
 
$
21,941

 
$
(81,319
)
 
$
62,611

 
$
(37,478
)
Non-routine items - pre-tax
 
 
 
 
 
 
 
 
 
 
Gain on Thailand insurance recovery
(5,220
)
 

 
(5,220
)
 

 
 
Loss on the sale of Brady Medical

 

 
3,675

 

 
 
Gain on the sale of Varitronics

 

 
(237
)
 

 
 
Non-routine items - pre-tax
(5,220
)
 

 
(1,782
)
 

 
 
 
 
 
 
 
 
 
 
 
Other items - pre-tax
 
 
 
 
 
 
 
 
 
Cost of goods sold
 
 
 
 
 
 
 
 
 
Purchase accounting expense related to inventory
1,530

 

 
1,530

 

 
Selling, general and administrative
 
 
 
 
 
 
 
 
 
PDC acquisition-related expenses
3,600

 

 
3,600

 

 
Restructuring charges
4,031

 

 
4,031

 

 
Impairment charge

 
115,688

 

 
115,688

 
Income taxes
 
 
 
 
 
 
 
 
 
Non-cash tax charge

 

 

 

 
 
Other items - pre-tax
9,161

 
115,688

 
9,161

 
115,688

 
 
 
 
 
 
 
 
 
 
 
Income Before Taxes Excluding Restructuring Charges,
 
 
 
 
 
 
 
 
Non-Routine Items, and Other (Non-GAAP measure)
$
25,882

 
$
34,369

 
$
69,990

 
$
78,210


Income Taxes Excluding Restructuring Charges, Non-Routine Items, and Other:
Brady is presenting the Non-GAAP measure "Income Taxes Excluding Restructuring Charges, Non-Routine Items, and Other." This is not a calculation based upon GAAP. The amounts included in this Non-GAAP measure are derived from amounts included in the Condensed Consolidated Statements of Income data. We do not view these items to be part of our sustainable results. We believe this measure provides an important perspective of underlying business trends and results and provides a more comparable measure from year to year. The table below provides a reconciliation of Income Taxes to Income Taxes Excluding Restructuring Charges, Non-Routine Items, and Other:
 
 
 
 
Three Months Ended January 31,
 
Six Months Ended January 31,
 
 
 
 
2013
 
2012
 
2013
 
2012
Income taxes (GAAP measure)
 
$
30,625

 
$
8,635

 
$
44,107

 
$
19,744

Non-routine items - tax effect
 
 
 
 
 
 
 
 
 
 
Gain on Thailand insurance recovery
(1,201
)
 

 
(1,201
)
 

 
 
Loss on the sale of Brady Medical

 

 
1,098

 

 
 
Gain on the sale of Varitronics

 

 
(875
)
 

 
 
Non-routine items - tax effect
(1,201
)
 

 
(978
)
 

 
 
 
 
 
 
 
 
 
 
 
Other items - tax effect
 
 
 
 
 
 
 
 
 
Cost of goods sold
 
 
 
 
 
 
 
 
 
Purchase accounting expense related to inventory
581

 

 
581

 

 
Selling, general and administrative
 
 
 
 
 
 
 
 
 
PDC acquisition-related expenses
641

 

 
641

 

 
Restructuring charges
750

 

 
750

 

 
Impairment charge

 

 

 

 
Income taxes
 
 
 
 
 
 
 
 
 
Non-cash tax charge
(25,000
)
 

 
(25,000
)
 

 
 
Other items - tax effect
(23,028
)
 

 
(23,028
)
 

 
 
 
 
 
 
 
 
 
 
 
Income Taxes Excluding Restructuring Charges,
 
 
 
 
 
 
 
 
Non-Routine Items, and Other (Non-GAAP measure)
$
6,396

 
$
8,635

 
$
20,101

 
$
19,744








GAAP TO NON-GAAP MEASURES
(Dollars in Thousands, Except Per Share Amounts)

Net Income Excluding Restructuring Charges, Non-Routine Items, and Other:
Brady is presenting the Non-GAAP measure "Net Income Excluding Restructuring Charges, Non-Routine Items, and Other." This is not a calculation based upon GAAP. The amounts included in this Non-GAAP measure are derived from amounts included in the Condensed Consolidated Statements of Income data. We do not view these items to be part of our sustainable results. We believe this measure provides an important perspective of underlying business trends and results and provides a more comparable measure from year to year. The table below provides a reconciliation of Net (Loss) Income to Net Income Excluding Restructuring Charges, Non-Routine Items, and Other:
 
 
 
 
Three Months Ended January 31,
 
Six Months Ended January 31,
 
 
 
 
2013
 
2012
 
2013
 
2012
Net (loss) income (GAAP measure)
 
$
(8,684
)
 
$
(89,954
)
 
$
18,504

 
$
(57,222
)
Non-routine items - net of tax
 
 
 
 
 
 
 
 
 
 
Gain on Thailand insurance recovery
(4,019
)
 

 
(4,019
)
 

 
 
Loss on the sale of Brady Medical

 

 
2,577

 

 
 
Gain on the sale of Varitronics

 

 
638

 

 
 
Non-routine items - net of tax
(4,019
)
 

 
(804
)
 

 
 
 
 
 
 
 
 
 
 
 
Other items - net of tax
 
 
 
 
 
 
 
 
 
Cost of goods sold
 
 
 
 
 
 
 
 
 
Purchase accounting expense related to inventory
949

 

 
949

 

 
Selling, general and administrative
 
 
 
 
 
 
 
 
 
PDC acquisition-related expenses
 
2,959

 

 
2,959

 

 
Restructuring charges
3,281

 

 
3,281

 

 
Impairment charge

 
115,688

 

 
115,688

 
Income taxes
 
 
 
 
 
 
 
 
 
Non-cash tax charge
25,000

 

 
25,000

 

 
 
Other items - net of tax
32,189

 
115,688

 
32,189

 
115,688

 
 
 
 
 
 
 
 
 
 
 
Net Income Excluding Restructuring Charges,
 
 
 
 
 
 
 
 
Non-Routine Items, and Other (Non-GAAP measure)
$
19,486

 
$
25,734

 
$
49,889

 
$
58,466


Diluted Net Income Per Class A Nonvoting Common Share Excluding Restructuring Charges, Non-Routine Items, and Other:
Brady is presenting the Non-GAAP measure "Diluted Net Income Per Class A Nonvoting Common Share Excluding Restructuring Charges, Non-Routine Items, and Other." This is not a calculation based upon GAAP. The amounts included in this Non-GAAP measure are derived from amounts included in the Condensed Consolidated Statements of Income data. We do not view these items to be part of our sustainable results. We believe this measure provides an important perspective of underlying business trends and results and provides a more comparable measure from year to year. The table below provides a reconciliation of Diluted Net (Loss) Income Per Class A Nonvoting Common Share to Diluted Net Income Per Class A Nonvoting Common Share Excluding Restructuring Charges, Non-Routine Items, and Other:
 
 
 
 
Three Months Ended January 31,
 
Six Months Ended January 31,
 
 
 
 
2013
 
2012
 
2013
 
2012
Diluted Net (Loss) Income Per Class A Nonvoting Share
$
(0.17
)
 
$
(1.72
)
 
$
0.36

 
$
(1.09
)
 
(GAAP measure)
 
 
 
 
 
 
 
 
Non-routine items
 
 
 
 
 
 
 
 
 
 
Gain on Thailand insurance recovery
(0.08
)
 

 
(0.08
)
 

 
 
Loss on the sale of Brady Medical

 

 
0.05

 

 
 
Gain on the sale of Varitronics

 

 
0.01

 

 
 
Non-routine items
(0.08
)
 

 
(0.02
)
 

 
 
 
 
 
 
 
 
 
 
 
Other items
 
 
 
 
 
 
 
 
 
Cost of goods sold
 
 
 
 
 
 
 
 
 
Purchase accounting expense related to inventory
0.02

 

 
0.02

 

 
Selling, general and administrative
 
 
 
 
 
 
 
 
 
PDC acquisition-related expenses
 
0.06

 

 
0.06

 

 
Restructuring charges
0.06

 

 
0.06

 

 
Impairment charge

 
2.21

 

 
2.21

 
Income taxes
 
 
 
 
 
 
 
 
 
Non-cash tax charge
0.49

 

 
0.49

 

 
 
Other items
0.63

 
2.21

 
0.63

 
2.21

 
 
 
 
 
 
 
 
 
 
 
Diluted Net Income Per Class A Nonvoting Share Excluding
 
 
 
 
 
 
 
 
Restructuring Charges, Non-Routine Items, and Other
 
 
 
 
 
 
 
 
(Non-GAAP measure)
$
0.38

 
$
0.49

 
$
0.97

 
$
1.12